Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma

By Richter Antje M.   Haag Tanja   Walesch Sara   Herrmann-Trost Peter   Marsch Wolfgang C.   Kutzner Heinz   Helmbold Peter   Dammann Reinhard H.  

Cancers, Vol. 5, Iss. 4, 2013-11 ,pp. : 1566-1576

MDPI

Access to resources Recommend Favorite

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1

By Volodko Natalia   Salla Mohamed   Zare Alaa   Abulghasem El-Arbi   Vincent Krista   Benesch Matthew G.K.   McMullen Todd P.W.   Bathe Oliver F.   Postovit Lynne   Baksh Shairaz  

Cancers, Vol. 8, Iss. 6, 2016-06 ,pp. : 55-55

MDPI

Access to resources Recommend Favorite

Lidocaine Sensitizes the Cytotoxicity of Cisplatin in Breast Cancer Cells via Up-Regulation of RARβ2 and RASSF1A Demethylation

By Li Kehan   Yang Jianxue   Han Xuechang  

International Journal of Molecular Sciences, Vol. 15, Iss. 12, 2014-12 ,pp. : 23519-23536

MDPI

Access to resources Recommend Favorite

lgl Regulates the Hippo Pathway Independently of Fat/Dachs, Kibra/Expanded/Merlin and dRASSF/dSTRIPAK

By Parsons Linda M.   Grzeschik Nicola A.   Richardson Helena E.  

Cancers, Vol. 6, Iss. 2, 2014-04 ,pp. : 879-896

MDPI

Access to resources Recommend Favorite

Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals

By Cao Xue   Tang Qiuqiong   Holland-Letz Tim   Gündert Melanie   Cuk Katarina   Schott Sarah   Heil Jörg   Golatta Michael   Sohn Christof   Schneeweiss Andreas   Burwinkel Barbara  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 900-900

MDPI

Access to resources Recommend Favorite